PROFILING DEGRADANTS OF PACLITAXEL USING LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY AND LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY SUBSTRUCTURAL TECHNIQUES
Kj. Volk et al., PROFILING DEGRADANTS OF PACLITAXEL USING LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY AND LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY SUBSTRUCTURAL TECHNIQUES, Journal of chromatography B. Biomedical sciences and applications, 696(1), 1997, pp. 99-115
Citations number
18
Categorie Soggetti
Chemistry Analytical","Biochemical Research Methods
A rapid and systematic strategy based on liquid chromatography-mass sp
ectrometry (LC-MS) profiling and liquid chromatography-tandem mass spe
ctrometry (LC-MS-MS) substructural techniques was utilized to elucidat
e the degradation products of paclitaxel, the active ingredient in Tax
ol. This strategy integrates, in a single instrumental approach, analy
tical HPLC, UV detection, full-scan electrospray MS, and MS-MS to rapi
dly and accurately elucidate structures of impurities and degradants.
In these studies, degradants induced by acid, base, peroxide, and ligh
t were profiled using LC-MS and LC-MS-MS methodologies resulting in an
LC-MS degradant database which includes information on molecular stru
ctures, chromatographic behavior, molecular mass, and MS-MS substructu
ral information. The stressing conditions which may cause drug degrada
tion are utilized to validate the analytical monitoring methods and se
rve as predictive tools for future formulation and packaging studies.
Degradation products formed upon exposure to basic conditions included
baccatin III, paclitaxel sidechain methyl ester, 10-deacetylpaclitaxe
l, and 7-epipaclitaxel. Degradation products formed upon exposure to a
cidic conditions included 10-deacetylpaclitaxel and the oxetane ring o
pened product, Treatment with hydrogen peroxide produced only 10-deace
tylpaclitaxel. Exposure to high intensity light produced a number of d
egradants. The most abundant photodegradant of paclitaxel corresponded
to an isomer which contains a C3-C11 bridge. These methodologies an a
pplicable at any stage of the drug product cycle from discovery throug
h development. This library of paclitaxel degradants provides a founda
tion for future development work regarding product monitoring, as well
as use as a diagnostic tool for new degradation products. (C) 1997 El
sevier Science B.V.